Oncology
Breast Cancer
Known as the "pink killer," breast cancer ranks 1st in mortality for female malignant tumors in China. Over 400,000 women are diagnosed annually, making precise companion diagnostics essential for targeted therapy selection.
Digital PCR Kits
Companion Diagnostics
- HER2 Gene Amplification Kit — quantitative assessment for anti-HER2 therapy eligibility
- PIK3CA Mutation Kit — detection for CDK4/6 inhibitor resistance profiling
- NTRK Fusion Kit — rare but actionable fusion for TRK inhibitors
